FDA Fast Track designation -- The BRTX-100 program was granted Fast Track status by the FDA for chronic lumbar disc disease ...

The sleep phase metrics will often suggest how rested you feel even with a full night’s sleep—for example, eight hours of ...

Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...

Net Loss -- $653,000, an improvement from the prior year’s net loss of $693,000.

Qiagen N.V. (QGEN) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 12:40 PM ESTCompany ParticipantsThierry Bernard - CEO, MD & ...

Q3 2025 Earnings Call November 12, 2025 8:00 AM ESTCompany ParticipantsJessie Yeung - Vice President of Finance, ...

Q3 2025 Management View CEO Stephen From emphasized a transition from assessment to execution, with a clear focus on reaching design freeze for the production-equivalent system by year-end 2026. From ...

Third quarter 2025 research and development expenses decreased by $2.7 million year-over-year to $7.8 million from $10.5 million for the third quarter of 2024. The decrease was primarily due to the ...

Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...

Mind Medicine Australia clinic joins Psyence BioMed’s expanding network of clinical sites as enrollment accelerates in the landmark Phase IIb study for Adjustment Disorder in palliative care This ...

Bio-Techne (TECH) and Nucleai announced the presentation of pivotal data from the SECOMBIT clinical trial at the Society for Immunotherapy of Cancer 2025 Annual Meeting. The study, conducted in ...

Strong clinical data doesn’t just move share prices – it can unlock lucrative global licensing deals for ASX-listed ...